FDA Announces Class I Recalls for Over One Million Pacemakers Due to Safety Issues

October 14, 2025 - 00:09

The FDA has issued final Class I recalls concerning significant safety concerns linked to a specific family of pacemakers. These recalls affect more than one million devices, highlighting the urgency of addressing potential risks to patients. The affected devices are part of a well-known pacemaker line that has been under scrutiny for some time.

In response to these safety issues, a software update has been made available to mitigate the risks associated with the pacemakers. This update is crucial for ensuring that the devices operate safely and effectively, thus safeguarding the health of individuals relying on them for cardiac support.

Moreover, the FDA has indicated that an additional software update is already in development, which aims to further enhance the performance and safety features of the pacemakers. Patients and healthcare providers are urged to stay informed about these updates and take appropriate action to ensure their devices are up to date.